Home > > > TAVR Market to Reach USD 18.8B by 2034 | CAGR 10.0%

TAVR Market to Reach USD 18.8B by 2034 | CAGR 10.0%

Author : shivani ghodake | Published On : 24 Sep 2026

According to a report by IntelMarketResearch, global Transcatheter Aortic Valve Replacement Market was valued at USD 8.0 billion in 2025 and is estimated to reach USD 8.8 billion in 2026. The market is projected to reach USD 18.8 billion by 2034, expanding at a CAGR of 10.0% during 2026–2034. Increasing adoption of minimally invasive valve replacement, the prevalence of aortic stenosis, technological advances in transcatheter valves, and expanding structural-heart programs are supporting market growth.

Explore the full report: https://www.intelmarketresearch.com/transcatheter-aortic-valve-replacement-market-12778

Why Is Demand Increasing

 

  • Minimally Invasive Treatment — TAVR provides a catheter-based alternative to conventional open-heart valve replacement for appropriately selected patients, supporting continued adoption of less-invasive structural-heart procedures.
  • Aortic Stenosis Burden — The prevalence of aortic valve disease, particularly among aging populations, is creating a growing clinical need for valve replacement procedures.
  • Device Innovation — Improvements in valve design, delivery systems, positioning, sealing, and procedural imaging are expanding the capabilities of transcatheter interventions.

 

Clinical & Reimbursement Watch: Structural Heart Care Expands

TAVR adoption is closely linked to patient selection, clinical evidence, hospital infrastructure, specialist expertise, reimbursement frameworks, and access to structural-heart programs. Continued device development is also supporting broader procedural capabilities and the treatment of increasingly diverse patient populations.

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/12778/transcatheter-aortic-valve-replacement-market

Segmentation Highlights

 

  • By Valve Type — Balloon-Expandable Valves and Self-Expanding Valves represent major technology categories used in transcatheter aortic valve procedures.
  • By Application — Aortic Stenosis remains the principal clinical indication, with transcatheter valve technologies increasingly integrated into structural-heart treatment pathways.
  • By End User — Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Laboratories represent key procedural settings.

 

Regional Outlook

 

  • North America Leads — North America is the largest regional market, supported by established structural-heart programs, advanced cardiovascular infrastructure, reimbursement pathways, and adoption of minimally invasive valve procedures.
  • Asia-Pacific Expands — Asia-Pacific presents significant growth opportunities as healthcare infrastructure improves, awareness of valvular heart disease increases, and access to advanced cardiovascular procedures expands.

 

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/12778/transcatheter-aortic-valve-replacement-market

Why This Market Matters

The TAVR market sits at the intersection of cardiovascular disease management, minimally invasive intervention, medical-device innovation, and structural-heart care. Advances in valve durability, delivery systems, imaging, procedural planning, and patient selection are influencing clinical adoption. Healthcare providers are also investing in dedicated heart teams and catheterization infrastructure to support increasing procedure volumes and complex structural-heart interventions.

Competitive Landscape

 

  • Edwards Lifesciences — Maintains a major transcatheter heart-valve portfolio with technologies focused on aortic valve replacement.
  • Medtronic — Competes through self-expanding transcatheter valve systems and a broad cardiovascular-device portfolio.
  • Boston Scientific — Participates in structural-heart intervention with transcatheter valve and procedural technologies.
  • Abbott — Maintains a broad structural-heart portfolio spanning valve repair, replacement, and related cardiovascular technologies.
  • Meril Life Sciences — Develops transcatheter cardiovascular devices and expands access to structural-heart technologies.

 

View the full report: https://www.intelmarketresearch.com/transcatheter-aortic-valve-replacement-market-12778

FAQ

What is the TAVR Market size in 2026? The global market is estimated at USD 8.8 billion in 2026.

What is the forecast for 2034? The market is projected to reach USD 18.8 billion by 2034 at a CAGR of 10.0%.

Which region leads the TAVR Market? North America is the largest regional market.

What Does the Full Report Cover?

The full report provides comprehensive analysis of the global Transcatheter Aortic Valve Replacement Market, including market size and forecasts, valve technologies, clinical applications, end-user settings, regional markets, competitive landscape, procedural trends, structural-heart programs, patient-selection considerations, device innovation, delivery systems, imaging technologies, reimbursement dynamics, and growth opportunities across major geographic markets through 2034.

View the complete report: https://www.intelmarketresearch.com/transcatheter-aortic-valve-replacement-market-12778

Download the free sample: https://www.intelmarketresearch.com/download-free-sample/12778/transcatheter-aortic-valve-replacement-market

Related Reports

 

 

About IntelMarketResearch

Intel Market Research provides market intelligence, industry analysis, competitive benchmarking, market sizing, forecasts, segmentation analysis, and strategic insights across global industries.

Contact Details

Intel Market Research website: https://www.intelmarketresearch.com/ Email: [email protected] Phone: +91 9169164321